pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
duvelisib
Copiktra (duvelisib)
T-Cell Lymphomas
Secura Bio Inc
Preclinical
edodekin alfa SR
edodekin alfa
Pancreatic Cancer
TherapyX Inc
Phase 2
efarindodekin alfa
efarindodekin alfa[INN]
Cervical Cancer
$GILD
GILEAD SCIENCES, INC.
Phase 2
← prev
page 45 of 62
next →
Pain
89
Neurology
1
efgitasialase alfa
efgitasialase alfa
Breast Cancer
Palleon Pharmaceuticals Inc
Phase 2
efineptakin alfa
efineptakin alfa
Radiation Toxicity (Radiation Sickness, Acute Radiation S…
NeoImmuneTech Inc
Phase 3
eflornithine
eflornithine [INN]
Anaplastic Astrocytoma
Orbus Therapeutics Inc
Phase 3
eftilagimod alfa
eftilagimod alfa [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$IMMP
IMMUTEP Ltd
Marketed
elacestrant hydrochloride
Orserdu (elacestrant hydrochloride)
Metastatic Breast Cancer
A. Menarini Industrie Farmaceutiche Riunite Srl
Phase 3
elenestinib
elenestinib
Systemic Mastocytosis
Blueprint Medicines Corp
Preclinical
elesclomol
elesclomol
Endometrial Cancer
Edison Oncology Holding Corp
Phase 2
elironrasib
elironrasib
Non-Small Cell Lung Cancer
$RVMD
Revolution Medicines, Inc.
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
Marketed
elotuzumab
Empliciti (elotuzumab)
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
Phase 2
elraglusib
elraglusib
Neuroblastoma
$ACTU
ACTUATE THERAPEUTICS, INC.
Phase 3
elritercept
elritercept
Anemia
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
Phase 2
elzovantinib
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
Phase 3
emactuzumab
emactuzumab
Tenosynovial Giant Cell Tumor
SynOx Therapeutics Ltd
Phase 1
emaretamig
emaretamig [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$XNCR
Xencor Inc
Phase 1
emiltatug ledadotin
emiltatug ledadotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$DAWN
Day One Biopharmaceuticals, Inc.
Phase 1
emunkitug
emunkitug [INN]
Cervical Cancer
HiFiBiO Therapeutics Inc
Marketed
enasidenib mesylate
Idhifa (enasidenib mesylate)
Refractory Acute Myeloid Leukemia
Bristol-Myers Squibb Co
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$ATOS
ATOSSA THERAPEUTICS, INC.
Phase 2
eniluracil
eniluracil
Metastatic Breast Cancer
$PCSA
Processa Pharmaceuticals, Inc.
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORIC
Oric Pharmaceuticals, Inc.
Marketed
entrectinib
Rozlytrek (entrectinib)
Non-Small Cell Lung Cancer
F. Hoffmann-La Roche Ltd
Phase 2
enzomenib tartrate
enzomenib tartrate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Sumitomo Pharma Co Ltd
Phase 2
epsametostat
epsametostat [INN]
Peripheral T-Cell Lymphomas (PTCL)
Shanghai Haihe Biopharma Co Ltd
Marketed
eribulin mesylate
Halaven (eribulin mesylate)
Liposarcoma
Eisai Co Ltd
Marketed
erlotinib hydrochloride
Erlotinib Hydrochloride
Non-Small Cell Lung Cancer
NATCO Pharma Inc.
